東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pathophysiology of ischemia reperfus...

Ahmed, Naseer,

FindBook

Google Book

Amazon

博客來

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection/ Naseer Ahmed.
作者:	Ahmed, Naseer,
出版者:	London :Academic Press, an imprint of Elsevier, : 2019.,
面頁冊數:	1 online resource :ill., map
標題:	Reperfusion injury - Pathophysiology. -
電子資源:	https://www.sciencedirect.com/science/book/9780128180235
ISBN:	9780128182536 (electronic bk.)

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
Ahmed, Naseer,

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection[electronic resource] /Naseer Ahmed. - London :Academic Press, an imprint of Elsevier,2019. - 1 online resource :ill., map

Includes bibliographical references and index.

Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.

ISBN: 9780128182536 (electronic bk.)Subjects--Topical Terms:

3509599
Reperfusion injury
--Pathophysiology.Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RB144.5

Dewey Class. No.: 616.1/3

National Library of Medicine Call No.: 2019 F-778

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
LDR:01946cmm a2200277 a 4500 001 2246288
006 m o d
007 cr cnu|||unuuu
008 211223s2019 enkab gob 001 0 eng d
020 $a 9780128182536 (electronic bk.)
020 $a 0128182539 (electronic bk.)
020 $a 9780128180235
020 $a 0128180234
035 $a (OCoLC)1103605858
035 $a on1103605858
040 $a N$T $b eng $c N$T $d N$T $d EBLCP $d OPELS $d UKMGB $d OCLCF $d UKAHL $d OCLCQ $d ERF $d LVT $d UX1 $d VT2 $d OCLCO $d OCLCA
041 0 $a eng
050 4 $a RB144.5
060 0 0 $a 2019 F-778
060 1 0 $a WG 282
082 0 4 $a 616.1/3 $2 23
100 1 $a Ahmed, Naseer, $e author. $3 3509598
245 1 0 $a Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection $h [electronic resource] / $c Naseer Ahmed.
260 $a London : $b Academic Press, an imprint of Elsevier, $c 2019.
300 $a 1 online resource : $b ill., map
504 $a Includes bibliographical references and index.
520 $a Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.
650 0 $a Reperfusion injury $x Pathophysiology. $3 3509599
650 0 $a Ischemia. $3 867591
650 0 $a Immunosuppressive agents. $3 1531038
650 1 2 $a Myocardial Reperfusion Injury $x physiopathology. $3 805415
650 2 2 $a Fingolimod Hydrochloride $x therapeutic use. $3 3509600
650 2 2 $a Myocardial Ischemia. $3 1961522
650 7 $a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh $3 1614811
650 7 $a MEDICAL $x Clinical Medicine. $2 bisacsh $3 1457888
650 7 $a MEDICAL $x Diseases. $2 bisacsh $3 1614812
650 7 $a MEDICAL $x Evidence-Based Medicine. $2 bisacsh $3 1615052
650 7 $a MEDICAL $x Internal Medicine. $2 bisacsh $3 1615053
655 0 $a Electronic books. $2 lcsh $3 542853
856 4 0 $u https://www.sciencedirect.com/science/book/9780128180235